Ethionamide
From Wikipedia, the free encyclopedia
 |
|
|
Ethionamide
|
|
| Systematic (IUPAC) name | |
| 2-ethylpyridine-4-carbothioamide | |
| Identifiers | |
| CAS number | 536-33-4 |
| ATC code | J04AD03 |
| PubChem | 2761171 |
| DrugBank | APRD00961 |
| Chemical data | |
| Formula | C8H10N2S |
| Mol. weight | 166.244 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Protein binding | Approximately 30% bound to proteins. |
| Metabolism | ? |
| Half life | 2 to 3 hours |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Ethionamide (2-ethylthioisonicotinamide, Trecator SC®) is an antibiotic used in the treatment of tuberculosis.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
| Antimycobacterials (J04) edit | ||
|---|---|---|
| Tuberculosis: |
Aminosalicylic acid, Calcium aminosalicylate, Capreomycin, Cycloserine, Ethambutol, Ethionamide, Isoniazid, Morinamide, Protionamide, Pyrazinamide, Rifabutin, Rifampicin, Rifamycin, Rifapentin, Sodium aminosalicylate, Terizidone, Tiocarlide |
|
| Leprosy: | ||
